Determination of Fluoxetine and Norfluoxetine in Human Serum and Urine by HPLC Using a Cholester Column with Fluorescence Detection
- 30 March 2009
- journal article
- research article
- Published by Taylor & Francis Ltd in Journal of Liquid Chromatography & Related Technologies
- Vol. 32 (8), 1141-1151
- https://doi.org/10.1080/10826070902841844
Abstract
Fluoxetine (FLX), a selective serotonin reuptake inhibitor, is mainly demethylated to norfluoxetine (NFLX). In this study, FLX and NFLX levels in human serum and urine (each 100 µL) were simultaneously analyzed by HPLC fluorescence detection on a Cholester column after pre-column derivatization with 4-fluoro-7-nitro-2,1,3-benzoxadiazole (NBD-F). After basic extraction of the samples into pentane, derivatization with NBD-F was conducted in borate buffer (pH 8.5) at 70°C for 2 min. Protriptyline was utilized as an internal standard. The regression equations for FLX hydrochloride and NFLX hydrochloride in human serum showed good linearity in the range of 0.01–0.5 µg/mL with the detection limit of 0.005 µg/mL, and in the range of 0.005–0.5 µg/mL with the detection limit of 0.002 µg/mL, respectively. The corresponding values for human urine were 0.1–0.5 µg/mL with the detection limit of 0.06 µg/mL, and 0.1–0.5 µg/mL with the detection limit of 0.04 µg/mL, respectively. The coefficients of variation were less than 15.7% with good recovery. Our method is useful for a simple and sensitive determination of FLX and NFLX in human serum and urine using a sample volume as small as 100 µL, and should be suitable for therapeutic drug monitoring.Keywords
This publication has 19 references indexed in Scilit:
- Simultaneous determination of citalopram, fluoxetine and their main metabolites in human urine samples by solid-phase microextraction coupled with high-performance liquid chromatographyJournal of Pharmaceutical and Biomedical Analysis, 2008
- Combined use of carbon nanotubes and ionic liquid to improve the determination of antidepressants in urine samples by liquid chromatographyAnalytical and Bioanalytical Chemistry, 2008
- Reliable HPLC method for therapeutic drug monitoring of frequently prescribed tricyclic and nontricyclic antidepressantsJournal of Pharmaceutical and Biomedical Analysis, 2007
- Comparison of liquid chromatography with fluorescence detection to liquid chromatography–mass spectrometry for the determination of fluoxetine and norfluoxetine in human plasmaJournal of Chromatography B, 2006
- Simultaneous determination of fluoxetine, citalopram, paroxetine, venlafaxine in plasma by high performance liquid chromatography–electrospray ionization mass spectrometry (HPLC–MS/ESI)Journal of Chromatography B, 2005
- Pharmacokinetic-Pharmacodynamic Relationship of the Selective Serotonin Reuptake Inhibitors???Clinical Pharmacokinetics, 1996
- Clinical Pharmacokinetics of FluoxetineClinical Pharmacokinetics, 1994
- Norfluoxetine Enantiomers as Inhibitors of Serotonin Uptake in Rat BrainNeuropsychopharmacology, 1993
- Fluoxetine, a Highly Selective Serotonin Reuptake Inhibitor: A Review of Preclinical StudiesThe British Journal of Psychiatry, 1988
- Fluoxetine, a selective serotonin uptake inhibitorClinical Pharmacology & Therapeutics, 1978